MPG.eBooks - Description: Clinical review report

Cover Image

Read Now

Clinical review report Insulin degludec (Tresiba) (Novo Nordisk Canada Inc)

The objective of the current review is to perform a systematic review of the beneficial and harmful effects of insulin degludec (IDeg) for the treatment of adults with diabetes mellitus to improve glycemic control

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2017, December 2017
Edition:	Version 1.0
Series:	CADTH common drug review
Subjects:	Adult Canada Diabetes Mellitus / Drug Therapy Hypoglycemic Agents / Therapeutic Use Insulin, Long-acting / Therapeutic Use
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK533972
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of the current review is to perform a systematic review of the beneficial and harmful effects of insulin degludec (IDeg) for the treatment of adults with diabetes mellitus to improve glycemic control
Physical Description:	1 PDF file (170 pages) illustrations